BIAF vs. ULY

Last updated Apr 1, 2026

Compare and contrast key facts about bioAffinity Technologies Inc. (BIAF) and Urgent.ly Inc. Common Stock (ULY).

Performance

BIAF vs. ULY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in bioAffinity Technologies Inc. (BIAF) and Urgent.ly Inc. Common Stock (ULY). The values are adjusted to include any dividend payments, if applicable.

BIAF vs. ULY - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023
BIAF bioAffinity Technologies Inc.	224.58%	-95.68%	-38.12%	8.93%
ULY Urgent.ly Inc. Common Stock	84.25%	-52.29%	-83.91%	-44.47%

Fundamentals

EPS BIAF : -$15.79 ULY : -$13.78
PS Ratio BIAF : 0.53 ULY : 0.06
Total Revenue (TTM) BIAF : $6.78M ULY : $129.19M
Gross Profit (TTM) BIAF : $1.62M ULY : $31.48M
EBITDA (TTM) BIAF : -$14.11M ULY : -$4.02M

Returns By Period

In the year-to-date period, BIAF achieves a 224.58% return, which is significantly higher than ULY's 84.25% return.

BIAF

• 1D: 8.19%
• 1M: 261.32%
• YTD: 224.58%
• 6M: 29.39%
• 1Y: -50.90%
• 3Y*: -59.27%
• 5Y*: —
• 10Y*: —

ULY

• 1D: 0.00%
• 1M: 177.32%
• YTD: 84.25%
• 6M: 66.56%
• 1Y: 15.20%
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

BIAF vs. ULY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BIAF

BIAF Risk / Return Rank: 52
BIAF Sharpe Ratio Rank: 34
BIAF Sortino Ratio Rank: 87
BIAF Omega Ratio Rank: 83
BIAF Calmar Ratio Rank: 24
BIAF Martin Ratio Rank: 31

ULY

ULY Risk / Return Rank: 59
ULY Sharpe Ratio Rank: 43
ULY Sortino Ratio Rank: 85
ULY Omega Ratio Rank: 80
ULY Calmar Ratio Rank: 44
ULY Martin Ratio Rank: 43

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BIAF vs. ULY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for bioAffinity Technologies Inc. (BIAF) and Urgent.ly Inc. Common Stock (ULY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	BIAF	ULY	Difference
Sharpe ratio Return per unit of total volatility	-0.13	0.06	-0.20
Sortino ratio Return per unit of downside risk	2.62	2.46	+0.15
Omega ratio Gain probability vs. loss probability	1.31	1.29	+0.02
Calmar ratio Return relative to maximum drawdown	-0.52	0.14	-0.67
Martin ratio Return relative to average drawdown	-0.61	0.18	-0.79
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

BIAF vs. ULY - Sharpe Ratio Comparison

The current BIAF Sharpe Ratio is -0.13, which is lower than the ULY Sharpe Ratio of 0.06. The chart below compares the historical Sharpe Ratios of BIAF and ULY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	BIAF	ULY	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.13	0.06	-0.20
Sharpe Ratio (All Time) Calculated using the full available price history	-0.30	-0.36	+0.06

Correlation

The correlation between BIAF and ULY is 0.06, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

BIAF vs. ULY - Dividend Comparison

Neither BIAF nor ULY has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

BIAF vs. ULY - Drawdown Comparison

The maximum BIAF drawdown since its inception was -99.70%, roughly equal to the maximum ULY drawdown of -97.43%. Use the drawdown chart below to compare losses from any high point for BIAF and ULY.

Drawdown Indicators

	BIAF	ULY	Difference
Max Drawdown Largest peak-to-trough decline	-99.70%	-97.43%	-2.27%
Max Drawdown (1Y) Largest decline over 1 year	-97.71%	-88.19%	-9.52%
Current Drawdown Current decline from peak	-98.46%	-92.15%	-6.31%
Average Drawdown Average peak-to-trough decline	-83.60%	-80.77%	-2.83%
Ulcer Index Depth and duration of drawdowns from previous peaks	83.66%	70.61%	+13.05%

Volatility

BIAF vs. ULY - Volatility Comparison

bioAffinity Technologies Inc. (BIAF) has a higher volatility of 104.73% compared to Urgent.ly Inc. Common Stock (ULY) at 97.74%. This indicates that BIAF's price experiences larger fluctuations and is considered to be riskier than ULY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	BIAF	ULY	Difference
Volatility (1M) Calculated over the trailing 1-month period	104.73%	97.74%	+6.99%
Volatility (6M) Calculated over the trailing 6-month period	130.79%	126.20%	+4.59%
Volatility (1Y) Calculated over the trailing 1-year period	383.26%	236.37%	+146.89%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	228.12%	179.54%	+48.58%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	228.12%	179.54%	+48.58%

Financials